Six F&O stocks, including Biocon, saw a sharp rise in futures open interest on December 4, signalling a fresh build-up in derivatives positions.Read More
Diagnostic companies delivered strong Q2 earnings driven by volume growth and deeper penetration, says SBI Cap Securities’ Sunny Agrawal. Midcap IT continues to outperform on rupee tailwinds and easing global uncertainty, though valuations remain high. Agrawal expects the RBI to pause rate cuts and advises caution on richly valued Kaynes Technology amid governance concerns.Read More
Meesho IPO: The company has priced its issue at ₹105–111 per share and is pitching itself as a fast-growing, low-cost marketplace with deep reach in India’s Tier-2 and Tier-3 cities. The IPO comprises a fresh issue of ₹4,250 crore and an offer for sale worth ₹1,171.20 crore.Read More
Global hedge funds are ending 2025 on a strong footing, delivering nearly 15% returns through November, driven by stock pickers, quant strategies, and a standout rally in healthcare. While long-short equity funds outperformed major U.S. indices, TMT-focused funds lagged due to a tech sell-off. Regionally, managers remained bullish on North America, added exposure to Japan, and pared positions in Europe and Hong Kong.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
